Begin typing your search above and press return to search.

BBCI, Kochi institute sign MoU for research

By Staff Reporter
  • Whatsapp
  • Telegram
  • Linkedin
  • Print
  • koo
  • Whatsapp
  • Telegram
  • Linkedin
  • Print
  • koo
  • Whatsapp
  • Telegram
  • Linkedin
  • Print
  • koo

GUWAHATI, March 19 - The Dr B Borooah Cancer Institute (BBCI) and the Amrita Institute of Medical Sciences of Kochi in Kerala have signed a memorandum of understanding (MoU) for clinical, academic and research collaboration.

The MoU was signed at a function held at the BBCI auditorium a couple of days back by Dr AC Kataki on behalf of BBCI and Dr Debnarayan Dutta, head of the Department of Radiation Oncology, on behalf of the Amrita Institute of Medical Sciences (AIMS).

The function was attended by Dr R Bhuyan, Director of Health Services, as the chief guest. As per the MoU, postgraduate students from both the institutes will participate in exchange teaching and training programmes.

Faculties from AIMS, Kochi, will participate in clinical and academic programmes at BBCI at four to six-month intervals. Faculties from BBCI will also get an opportunity for training at AIMS, Kochi.

The MoU is expected to contribute to capacity development in the field of oncology and improve the standard of care in this part of the country.

It is also expected that AIMS and BBCI can be mutually supportive for capacity development in various fields of oncology, clinical and academic collaboration and advancement of research projects for the benefit of the people of the country in general and the Northeastern region in particular.

According to experts, Kerala has the best healthcare delivery system in the country at present.

The incidence of cancer in Assam as per the Population Based Cancer Registry of ICMR is the fourth highest in the country.

Cancer of the oesophagus, hypopharynx, gall bladder, prostate and ovary is very common in Assam, whereas cancer of the lung, thyroid and breast is more common in Kerala.

AIMS is a state of the art hospital with an annual turnover of 8,00,000 outpatients and nearly 50,000 inpatients. There are 12 superspecialty departments, 45 other departments, 450 support staff and 670 faculty members.

With extensive facilities comprising 25 modern operating theatres, 275 equipped intensive-care beds, a fully computerised and networked hospital information system, a fully digital radiology department, 17 NABL-accredited clinical laboratories and a 24x7 telemedicine service, AIMS offers a total and comprehensive healthcare solution comparable to the best hospitals in the world.

BBCI is a recognised institute for cancer treatment, education and research, and experts hope the MoU can act as a platform for broad-based collaboration in oncology between AIMS and BBCI.

More than 10,000 new cancer patients and approximately 80,000 old cancer patients visit the institute every year.

Next Story
Similar Posts
BBCI, Kochi institute sign MoU for research

GUWAHATI, March 19 - The Dr B Borooah Cancer Institute (BBCI) and the Amrita Institute of Medical Sciences of Kochi in Kerala have signed a memorandum of understanding (MoU) for clinical, academic and research collaboration.

The MoU was signed at a function held at the BBCI auditorium a couple of days back by Dr AC Kataki on behalf of BBCI and Dr Debnarayan Dutta, head of the Department of Radiation Oncology, on behalf of the Amrita Institute of Medical Sciences (AIMS).

The function was attended by Dr R Bhuyan, Director of Health Services, as the chief guest. As per the MoU, postgraduate students from both the institutes will participate in exchange teaching and training programmes.

Faculties from AIMS, Kochi, will participate in clinical and academic programmes at BBCI at four to six-month intervals. Faculties from BBCI will also get an opportunity for training at AIMS, Kochi.

The MoU is expected to contribute to capacity development in the field of oncology and improve the standard of care in this part of the country.

It is also expected that AIMS and BBCI can be mutually supportive for capacity development in various fields of oncology, clinical and academic collaboration and advancement of research projects for the benefit of the people of the country in general and the Northeastern region in particular.

According to experts, Kerala has the best healthcare delivery system in the country at present.

The incidence of cancer in Assam as per the Population Based Cancer Registry of ICMR is the fourth highest in the country.

Cancer of the oesophagus, hypopharynx, gall bladder, prostate and ovary is very common in Assam, whereas cancer of the lung, thyroid and breast is more common in Kerala.

AIMS is a state of the art hospital with an annual turnover of 8,00,000 outpatients and nearly 50,000 inpatients. There are 12 superspecialty departments, 45 other departments, 450 support staff and 670 faculty members.

With extensive facilities comprising 25 modern operating theatres, 275 equipped intensive-care beds, a fully computerised and networked hospital information system, a fully digital radiology department, 17 NABL-accredited clinical laboratories and a 24x7 telemedicine service, AIMS offers a total and comprehensive healthcare solution comparable to the best hospitals in the world.

BBCI is a recognised institute for cancer treatment, education and research, and experts hope the MoU can act as a platform for broad-based collaboration in oncology between AIMS and BBCI.

More than 10,000 new cancer patients and approximately 80,000 old cancer patients visit the institute every year.